World's Best Scientists 2026 revealed!
Elio Scarpini

Elio Scarpini

D-Index & Metrics

Medicine

D-Index
99
Citations
47343
World Ranking
8453
National Ranking
283

Overview

Elio Scarpini is affiliated with the University of Milan in Italy and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research primarily focuses on neurology and molecular biology, with significant work also in physiology, pathology and forensic medicine, and psychiatry and mental health.

Scarpini's academic output spans several prominent topics, including:

  • Alzheimer's disease research and treatments
  • Multiple sclerosis research studies
  • Amyotrophic lateral sclerosis research
  • Dementia and cognitive impairment research
  • Polyomavirus and related diseases
  • Extracellular vesicles in disease
  • Advanced neuroimaging techniques and applications

Frequent publication venues where Scarpini has contributed include:

  • Journal of Alzheimer s Disease
  • Neurology
  • Cells
  • International Journal of Molecular Sciences
  • Frontiers in Neurology

Among recent papers, some notable publications include:

  • "Common variants in Alzheimer's disease and risk stratification by polygenic risk scores" (2021, Nature Communications)
  • "Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders" (2020, Brain)
  • "Role of Oxidative Damage in Alzheimer's Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery" (2021, Antioxidants)
  • "Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation" (2021, Neurology)
  • "Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies" (2021, Therapeutic Advances in Neurological Disorders)

Scarpini frequently collaborates with several researchers, including:

  • Daniela Galimberti
  • Chiara Fenoglio
  • Andrea Arighi
  • Giorgio Fumagalli
  • Tiziana Carandini

Best Publications

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

    Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish

  • Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

    Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Treatment of Alzheimer's disease; current status and new perspectives

    Elio Scarpini;Philip Scheltens;Howard Feldman

  • Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

    Lawrence S Honig;Bruno Vellas;Michael M Woodward;Mercè Boada

  • APOE and Alzheimer disease: a major gene with semi-dominant inheritance

    E Genin;D Hannequin;D Wallon;K Sleegers

  • Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis

    Jonathan D Rohrer;Jennifer M Nicholas;Jennifer M Nicholas;David M Cash;John van Swieten

  • Transcranial direct current stimulation improves recognition memory in Alzheimer disease

    R. Ferrucci;F. Mameli;I. Guidi;S. Mrakic-Sposta

  • The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

    Niklas Mattsson;Ulf Andreasson;Staffan Persson;Hiroyuki Arai

  • Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.

    Howard H. Feldman;Steven Ferris;Bengt Winblad;Nikolaos Sfikas

  • Frontotemporal dementia and its subtypes: a genome-wide association study

    Raffaele Ferrari;Raffaele Ferrari;Dena G Hernandez;Dena G Hernandez;Michael A Nalls;Jonathan D Rohrer

  • A Polymorphism in CALHM1 Influences Ca2+ Homeostasis, Aβ Levels, and Alzheimer's Disease Risk

    Ute Dreses-Werringloer;Jean Charles Lambert;Valérie Vingtdeux;Haitian Zhao

  • Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

    Daniela Galimberti;Niki Schoonenboom;Philip Scheltens;Chiara Fenoglio

  • Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to alzheimer disease

    Davide Anchisi;Barbara Borroni;Massimo Franceschi;Nasser Kerrouche

  • Prolonged visual memory enhancement after direct current stimulation in Alzheimer's disease

    Paulo Sergio Boggio;Roberta Ferrucci;Roberta Ferrucci;Francesca Mameli;Débora Martins

  • Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial.

    P. Scheltens;J.W.R. Twisk;R. Blesa;E. Scarpini

  • Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    J. Kuhle;G. Disanto;R. Dobson;R. Adiutori

  • Plasma ghrelin concentrations in elderly subjects: Comparison with anorexic and obese patients

    AE Rigamonti;AI Pincelli;B Corra;R Viarengo

  • Molecular Mechanisms Involved in Lymphocyte Recruitment in Inflamed Brain Microvessels: Critical Roles for P-Selectin Glycoprotein Ligand-1 and Heterotrimeric Gi-Linked Receptors

    Laura Piccio;Barbara Rossi;Elio Scarpini;Carlo Laudanna

  • SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

    Elisa Rubino;Innocenzo Rainero;Adriano Chiò;Ekaterina Rogaeva

Frequent Co-Authors

Daniela Galimberti
Daniela Galimberti University of Milan
Nereo Bresolin
Nereo Bresolin University of Milan
Stefano F. Cappa
Stefano F. Cappa Istituto Universitario Di Studi Superiori Di Pavia
Sandro Sorbi
Sandro Sorbi University of Florence
Giuliano Binetti
Giuliano Binetti Sacred Heart Hospital
Alessandro Padovani
Alessandro Padovani University of Brescia
Gianluigi Forloni
Gianluigi Forloni Mario Negri Institute for Pharmacological Research
Caroline Graff
Caroline Graff Karolinska University Hospital
Barbara Borroni
Barbara Borroni University of Brescia
Fabrizio Tagliavini
Fabrizio Tagliavini Istituto Neurologico Carlo Besta

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in alternative healthcare career routes or advancing your nursing qualifications, there are several online degree options to consider. Many professionals seek the fastest msn to dnp program to accelerate their entry into advanced practice roles. These programs are designed for registered nurses aiming for leadership positions or clinical expertise with minimal downtime.

For those looking for greater flexibility, some online dnp programs without clinicals are available, making it easier to balance studies with professional or personal commitments. Such options are ideal if you want to advance without spending extensive hours meeting in-person clinical requirements.

Entry-level candidates might consider a fast track lpn program online. These pathways are among the quickest ways to start a nursing career and serve as a stepping stone to further degrees.

Additionally, those interested in mental health can pursue an msn to pmhnp online to specialize as a psychiatric mental health nurse practitioner. This field is increasingly in demand, opening doors to rewarding and impactful careers.

Best Scientists Citing Elio Scarpini

Trending Scientists